Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Organovo Holdings Inc    ONVO

ORGANOVO HOLDINGS INC (ONVO)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/15/2017 11/16/2017 11/17/2017 11/20/2017 11/21/2017 Date
1.39(c) 1.45(c) 1.47(c) 1.54(c) 1.51 Last
682 520 683 769 546 725 1 170 139 279 856 Volume
+1.46% +4.32% +1.38% +4.76% -1.95% Change
More quotes
Financials ($)
Sales 2018 5,02 M
EBIT 2018 -38,2 M
Net income 2018 -39,4 M
Debt 2018 -
Yield 2018 -
Sales 2019 8,57 M
EBIT 2019 -36,7 M
Net income 2019 -39,6 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 32,8x
Capi. / Sales2019 19,2x
Capitalization 165 M
More Financials
Company
Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications.It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be... 
More about the company
Surperformance© ratings of Organovo Holdings Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ORGANOVO HOLDINGS INC
11/09 ORGANOVO : reports 2Q loss
11/09 ORGANOVO HOLDINGS, INC. : Results of Operations and Financial Condition, Financi..
11/09 ORGANOVO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
11/09 Organovo Announces Fiscal Second-Quarter 2018 Results; Company Shifts Commerc..
11/07 ORGANOVO : and Viscient Biosciences Collaborate to Develop Custom Research Platf..
11/06 Organovo and Viscient Biosciences Collaborate to Develop Custom Research Plat..
10/20 Organovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues f..
10/19 Organovo Announces Release Date for Fiscal Second-Quarter 2018 Financial Resu..
10/05 ORGANOVO HOLDINGS, INC. (NASDAQ : ONVO) Files An 8-K Results of Operations and F..
10/04 ORGANOVO HOLDINGS, INC. : Results of Operations and Financial Condition, Costs A..
More news
Sector news : Biotechnology & Medical Research - NEC
11/16 Recovery rally for European stocks leaves oil sector behind
11/13 Poor earnings updates keep European shares at seven-week low
11/13DJNOVARTIS : Vision Drug Shows Positive Results in Phase 3 Trials
11/03 Prosecutors search Metro offices in insider trading probe
11/01DJAs Experimental Treatments Grow, Families Face Tough Choices
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
11/09 Organovo Holdings' (ONVO) CEO Taylor Crouch on Q2 2018 Results - Earnings Cal..
11/09 Organovo FQ2 revenues down 2%; ytd cash flow down 13%; revenue guidance lower..
11/09 Organovo Holdings beats by $0.01, misses on revenue
11/08 Notable earnings after Thursday?s close
10/20 PREMARKET GAINERS AS OF 9 : 05 am
Chart ORGANOVO HOLDINGS INC
Duration : Period :
Organovo Holdings Inc Technical Analysis Chart | ONVO | US68620A1043 | 4-Traders
Technical analysis trends ORGANOVO HOLDINGS INC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 2,50 $
Spread / Average Target 62%
EPS Revisions
Managers
NameTitle
Taylor J. Crouch President, Chief Executive Officer & Director
Kirk D. Malloy Chairman
Craig S. Kussman Chief Financial Officer
Sharon Collins Presnell Chief Scientific Officer
James T. Glover Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ORGANOVO HOLDINGS INC-56.64%165
CELLTRION, INC.--.--%24 243
IQVIA HOLDINGS INC37.36%21 955
INCYTE CORPORATION5.19%20 882
LONZA GROUP59.15%19 698
ALNYLAM PHARMACEUTICALS, INC.240.57%12 601